» Articles » PMID: 38586172

Significance of the Wnt Signaling Pathway in Coronary Artery Atherosclerosis

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The progression of coronary atherosclerosis is an active and regulated process. The Wnt signaling pathway is thought to play an active role in the pathogenesis of several cardiovascular diseases; however, a better understanding of this system in atherosclerosis is yet to be unraveled.

Methods: In this study, real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting were used to quantify the expression of Wnt3a, Wnt5a, and Wnt5b in the human coronary plaque, and immunohistochemistry was used to identify sites of local expression. To determine the pathologic significance of increased Wnt, human vascular smooth muscle cells (vSMCs) were treated with Wnt3a, Wnt5a, and Wnt5b recombinant proteins and assessed for changes in cell differentiation and function.

Results: RT-PCR and Western blotting showed a significant increase in the expression of Wnt3a, Wnt5a, Wnt5b, and their receptors in diseased coronary arteries compared with that in non-diseased coronary arteries. Immunohistochemistry revealed an abundant expression of Wnt3a and Wnt5b in diseased coronary arteries, which contrasted with little or no signals in normal coronary arteries. Immunostaining of Wnt3a and Wnt5b was found largely in inflammatory cells and myointimal cells. The treatment of vSMCs with Wnt3a, Wnt5a, and Wnt5b resulted in increased vSMC differentiation, migration, calcification, oxidative stress, and impaired cholesterol handling.

Conclusions: This study demonstrates the upregulation of three important members of canonical and non-canonical Wnt signaling pathways and their receptors in coronary atherosclerosis and shows an important role for these molecules in plaque development through increased cellular remodeling and impaired cholesterol handling.

Citing Articles

From Cells to Plaques: The Molecular Pathways of Coronary Artery Calcification and Disease.

Mitsis A, Khattab E, Christodoulou E, Myrianthopoulos K, Myrianthefs M, Tzikas S J Clin Med. 2024; 13(21).

PMID: 39518492 PMC: 11545949. DOI: 10.3390/jcm13216352.


Lysyl Oxidase in Ectopic Cardiovascular Calcification: Role of Oxidative Stress.

Ballester-Servera C, Alonso J, Canes L, Vazquez-Sufuentes P, Garcia-Redondo A, Rodriguez C Antioxidants (Basel). 2024; 13(5).

PMID: 38790628 PMC: 11118817. DOI: 10.3390/antiox13050523.

References
1.
Borrell-Pages M, Romero J, Badimon L . LRP5 deficiency down-regulates Wnt signalling and promotes aortic lipid infiltration in hypercholesterolaemic mice. J Cell Mol Med. 2015; 19(4):770-7. PMC: 4395191. DOI: 10.1111/jcmm.12396. View

2.
Kajla S, Mondol A, Nagasawa A, Zhang Y, Kato M, Matsuno K . A crucial role for Nox 1 in redox-dependent regulation of Wnt-β-catenin signaling. FASEB J. 2012; 26(5):2049-59. DOI: 10.1096/fj.11-196360. View

3.
Lai K, Nguyen C, Lee K, Lee A, Lin D, Teo J . Convergence of Canonical and Non-Canonical Wnt Signal: Differential Kat3 Coactivator Usage. Curr Mol Pharmacol. 2019; 12(3):167-183. PMC: 6687580. DOI: 10.2174/1874467212666190304121131. View

4.
Akoumianakis I, Polkinghorne M, Antoniades C . Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications. Nat Rev Cardiol. 2022; 19(12):783-797. PMC: 9191761. DOI: 10.1038/s41569-022-00718-5. View

5.
Xu S, Ogura S, Chen J, Little P, Moss J, Liu P . LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci. 2012; 70(16):2859-72. PMC: 4142049. DOI: 10.1007/s00018-012-1194-z. View